NOCD Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
475
- Latest Deal Type
-
Series C1
- Latest Deal Amount
-
$5.7M
- Investors
-
16
NOCD General Information
Description
Developer of a telehealth application designed to assist in the self-treatment and monitoring of obsessive-compulsive disorder symptoms. The company's application guides patients through exposure and response prevention exercises and therapy that is especially effective for obsessive-compulsive disorder, enabling clinicians and researchers to improve obsessive-compulsive disorder treatment and connect with patients.
Contact Information
Website
www.treatmyocd.comCorporate Office
- 225 North Michigan Avenue
- Suite 1430
- Chicago, IL 60601
- United States
Corporate Office
- 225 North Michigan Avenue
- Suite 1430
- Chicago, IL 60601
- United States
NOCD Timeline
NOCD Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series C1) | 19-Aug-2024 | $5.7M | Completed | Generating Revenue | ||
| 7. Later Stage VC (Series C) | 18-Jan-2023 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series B) | 21-Sep-2021 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series A) | 08-Oct-2020 | Completed | Generating Revenue | |||
| 4. Debt - PPP | 29-Apr-2020 | Completed | Generating Revenue | |||
| 3. Seed Round | 01-Oct-2019 | Completed | Generating Revenue | |||
| 2. Seed Round | 12-Feb-2018 | $1M | $1.25M | Completed | Startup | |
| 1. Angel (individual) | 01-Sep-2016 | $250K | $250K | Completed | Startup |
NOCD Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C-1 | ||||||||
| Series C | ||||||||
| Series B-1 | ||||||||
| Series B | ||||||||
| Series A | ||||||||
| Seed-2 | 1,294,634 | $0.001000 | 8% | $3.09 | $3.09 | 1x | $3.09 | 9.74% |
| Seed-1 | 966,767 | $0.001000 | 8% | $1.66 | $1.66 | 1x | $1.66 | 7.27% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
NOCD Comparisons
Industry
Financing
Details
NOCD Competitors (8)
One of NOCD’s 8 competitors is Wellnite, a Venture Capital-Backed company based in San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Wellnite | Venture Capital-Backed | San Francisco, CA | ||||
| Talkspace | Formerly VC-backed | New York, NY | ||||
| AbleTo | Formerly PE-Backed | New York, NY | ||||
| MDLive | Venture Capital-Backed | Miramar, FL | ||||
| Lemonaid Health | Private Equity-Backed | San Francisco, CA |
NOCD Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
NOCD Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
NOCD Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Benz Cap | Family Office | Minority | ||
| Illinois Growth and Innovation Fund | Impact Investing | Minority | ||
| Longitude Capital | Venture Capital | Minority | ||
| The Cigna Group Ventures (Bloomfield) | Corporate Venture Capital | Minority | ||
| 7wire Ventures | Venture Capital | Minority |
NOCD Investments (1)
NOCD’s most recent deal was a Buyout/LBO with Rebound Health. The deal was made on 27-Jan-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Rebound Health | 27-Jan-2026 | Buyout/LBO | Clinics/Outpatient Services |
NOCD Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Rebound Health | San Francisco, CA | 2023 |
NOCD FAQs
-
When was NOCD founded?
NOCD was founded in 2014.
-
Where is NOCD headquartered?
NOCD is headquartered in Chicago, IL.
-
What is the size of NOCD?
NOCD has 475 total employees.
-
What industry is NOCD in?
NOCD’s primary industry is Clinics/Outpatient Services.
-
Is NOCD a private or public company?
NOCD is a Private company.
-
What is the current valuation of NOCD?
The current valuation of NOCD is .
-
What is NOCD’s current revenue?
The current revenue for NOCD is .
-
How much funding has NOCD raised over time?
NOCD has raised $90M.
-
Who are NOCD’s investors?
Benz Cap, Illinois Growth and Innovation Fund, Longitude Capital, The Cigna Group Ventures (Bloomfield), and 7wire Ventures are 5 of 16 investors who have invested in NOCD.
-
Who are NOCD’s competitors?
Wellnite, Talkspace, AbleTo, MDLive, and Lemonaid Health are some of the 8 competitors of NOCD.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
